These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 18166578)
1. Head lice, resistance, and malathion. Ross K Pediatrics; 2008 Jan; 121(1):222; author reply 222-3. PubMed ID: 18166578 [No Abstract] [Full Text] [Related]
2. Clinical response and safety of malathion shampoo for treatment of head lice in a primary school. Wananukul S; Chatproedprai S; Tempark T; Wananukul W J Med Assoc Thai; 2011 Apr; 94(4):465-9. PubMed ID: 21591532 [TBL] [Abstract][Full Text] [Related]
4. A randomized, assessor-blind, parallel-group, multicentre, phase IV comparative trial of a suffocant compared with malathion in the treatment of head lice in children. Greive KA; Lui AH; Barnes TM; Oppenheim VM Australas J Dermatol; 2010 Aug; 51(3):175-82. PubMed ID: 20695855 [TBL] [Abstract][Full Text] [Related]
5. Therapy for head lice based on life cycle, resistance, and safety considerations. Lebwohl M; Clark L; Levitt J Pediatrics; 2007 May; 119(5):965-74. PubMed ID: 17473098 [TBL] [Abstract][Full Text] [Related]
6. Malathion for head lice and scabies: treatment and safety considerations. Idriss S; Levitt J J Drugs Dermatol; 2009 Aug; 8(8):715-20. PubMed ID: 19663108 [TBL] [Abstract][Full Text] [Related]
7. [The efficacy of malathion against head lice]. de Boer R; van der Geest LP Ned Tijdschr Geneeskd; 1985 Apr; 129(17):793-6. PubMed ID: 4000292 [No Abstract] [Full Text] [Related]
8. Oral ivermectin for head lice: a comparison with 0.5 % topical malathion lotion. Nofal A J Dtsch Dermatol Ges; 2010 Dec; 8(12):985-8. PubMed ID: 20718901 [TBL] [Abstract][Full Text] [Related]
9. Getting the bugs out: FDA approves new treatment for head lice.. Child Health Alert; 2009 May; 27():2. PubMed ID: 19530262 [No Abstract] [Full Text] [Related]
10. Safety and efficacy of pediculicides for head lice. Burkhart CG; Burkhart CN Expert Opin Drug Saf; 2006 Jan; 5(1):169-79. PubMed ID: 16370965 [TBL] [Abstract][Full Text] [Related]
11. Head lice revisited: in vitro standardized tests and differences in malathion formulations. Burkhart CN; Burkhart CG Arch Dermatol; 2004 Apr; 140(4):488-9. PubMed ID: 15096384 [No Abstract] [Full Text] [Related]
12. Permethrin and malathion resistance in head lice: results of ex vivo and molecular assays. Bouvresse S; Berdjane Z; Durand R; Bouscaillou J; Izri A; Chosidow O J Am Acad Dermatol; 2012 Dec; 67(6):1143-50. PubMed ID: 22627039 [TBL] [Abstract][Full Text] [Related]
13. Malathion for treatment of Pediculus humanus var capitis infestation. Taplin D; Castillero PM; Spiegel J; Mercer S; Rivera AA; Schachner L JAMA; 1982 Jun; 247(22):3103-5. PubMed ID: 7043013 [TBL] [Abstract][Full Text] [Related]
14. Toxicity in head lice treatment. Macmillan I Aust Fam Physician; 2003 Nov; 32(11):871; author reply 871. PubMed ID: 14650779 [No Abstract] [Full Text] [Related]
16. Head lice treatments: Searching for the path of least resistance. Heymann WR J Am Acad Dermatol; 2009 Aug; 61(2):323-4. PubMed ID: 19615542 [TBL] [Abstract][Full Text] [Related]
17. Overview: the state of head lice management and control. Hansen RC Am J Manag Care; 2004 Sep; 10(9 Suppl):S260-3. PubMed ID: 15515629 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice. Meinking TL; Vicaria M; Eyerdam DH; Villar ME; Reyna S; Suarez G Pediatr Dermatol; 2004; 21(6):670-4. PubMed ID: 15575855 [TBL] [Abstract][Full Text] [Related]
20. Evidence in the treatment of head lice: drowning in a swamp of reviews. Lapeere H; Vander Stichele RH; Naeyaert JM Clin Infect Dis; 2003 Dec; 37(11):1580-2. PubMed ID: 14614685 [No Abstract] [Full Text] [Related] [Next] [New Search]